About Vamstar
Vamstar is a company based in London (United Kingdom) founded in 2019 by Richard Freeman. Vamstar has raised $11.2 million across 3 funding rounds from investors including Celltrion, AICapital and Dutch Founders Fund. Vamstar offers products and services including Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker. Vamstar operates in a competitive market with competitors including Tomorrow Health, SkyCell, Zoplar, AA Medical Store and Marken, among others.
- Headquarter London, United Kingdom
- Founders Richard Freeman
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vamstar Limited
- Date of Incorporation 12 Sep, 2019
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.2 M (USD)
in 3 rounds
-
Latest Funding Round
$9.5 M (USD), Series A
May 11, 2022
-
Investors
Celltrion
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vamstar
Vamstar offers a comprehensive portfolio of products and services, including Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker.
Offers data science tools for tendering and pricing optimization.
AI system for enhancing pharmaceutical tender bidding strategies.
Platform for processing and analyzing market data in life sciences.
Monitors net prices and revenue in pharmaceutical markets.
People of Vamstar
Unlock access to complete
Funding Insights of Vamstar
Vamstar has successfully raised a total of $11.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.5 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vamstar
Vamstar has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Celltrion, AICapital and Dutch Founders Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-first companies are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Early-stage investing and founder support services are offered globally by Antler.
|
Locked | Locked | Locked | |
|
Venture capital is provided to innovative startups by b2venture.
|
Locked | Locked | Locked |
Investor details for Vamstar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vamstar
Investment portfolio details for Vamstar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vamstar
Detailed financials for Vamstar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vamstar Comparisons
Peer comparison for Vamstar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vamstar
Vamstar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tomorrow Health, SkyCell, Zoplar, AA Medical Store and Marken, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of an online store for healthcare products
|
|
| Locked | Locked | Locked |
Temperature-controlled containers for pharmaceutical transport are provided.
|
|
| Locked | Locked | Locked |
B2B medical supply platform that simplifies procurement for hospitals and clinics by offering a wide range of medical devices, equipment, and consumables
|
|
| Locked | Locked | Locked |
New and pre-owned medical equipment is retailed online.
|
|
| Locked | Locked | Locked |
Provider of supply chain logistics solutions and services for pharma and medical devices industry
|
Detailed competitors of Vamstar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vamstar
Complete news archive for Vamstar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vamstar
Vamstar was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Vamstar is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Praful Mehta is the current CEO of Vamstar.
Vamstar is a funded company, having raised a total of $11.2M across 3 funding rounds to date.
Vamstar was founded in 2019 in London, United Kingdom, focusing on healthcare procurement. An AI-based platform is utilized for managing purchases, where natural language processing and deep learning extract data from websites, registries, and documents. Interactive dashboards and reports are generated to analyze buyer and competitor behaviors, aiding commercial decisions. AI is employed to match procurement needs with supplier capabilities.
Vamstar's top competitors include Tomorrow Health, SkyCell and Zoplar.
Vamstar offers Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker.
Vamstar has 7 investors. Key investors include Celltrion, AICapital, Dutch Founders Fund, Antler, and Mirae Asset Global Investments.
The valuation of Vamstar is $32.31M as of May 2022.